| Gene | Gene Mutation Frequency | COSMIC ID | AA Mutation | Type of Mutation | Frequency of Unique Mutation (%) | Drug Resistance | Drug Sensitivity |
| EGFR | 25% | COSM12979 | p.L858R | Substitution - Missense | 0.0686 | Afatinib, Erlotinib | Afatinib, Erlotinib, Gefitinib, BIBW2992 |
| EGFR | 25% | COSM13243 | p.?del | Deletion - In frame | 6.1082 | Afatinib, Erlotinib | Afatinib, Erlotinib, Gefitinib, BIBW2992 |
| EGFR | 25% | COSM12980 | p.E746_A750del | Deletion - In frame | 3.0723 | Afatinib, Erlotinib | Afatinib, Erlotinib, Gefitinib, BIBW2992 |
| EGFR | 25% | COSM6224 | p.L858R | Subsitituion-Missense | 2.5148 | Afatinib, Erlotinib | Afatinib, Erlotinib, Gefitinib, BIBW2992 |
| EGFR | 25% | COSM6223 | p.E746_A750delELREA | Deletion - In frame | 1.5876 | Afatinib, Erlotinib | Afatinib, Erlotinib, Gefitinib, BIBW2992 |
| EGFR | 25% | COSM21943 | p.T790M | Substitution - Missense | 0.8787 | Afatinib, Erlotinib | Afatinib, Erlotinib, Gefitinib, BIBW2992 |
| EGFR | 25% | COSM13173 | p.L861Q | Substitution - Missense | 0.2727 | Afatinib, Erlotinib | Afatinib, Erlotinib, Gefitinib, BIBW2992 |
| EGFR | 25% | COSM13564 | p.L747_P753>S | Complex - deletion inframe | 0.2121 | Afatinib, Erlotinib | Afatinib, Erlotinib, Gefitinib, BIBW2992 |
| EGFR | 25% | COSM13448 | p.G719A | Substitution - Missense | 0.1212 | Afatinib, Erlotinib | Afatinib, Erlotinib, Gefitinib, BIBW2992 |
| EGFR | 25% | COSM6240 | p.T790M | Substitution - Missense | 0.0909 | Afatinib, Erlotinib | Afatinib, Erlotinib, Gefitinib, BIBW2992 |
| EGFR | 25% | COSM18486 | p.S768I | Substitution - Missense | 0.0879 | Afatinib, Erlotinib | Afatinib, Erlotinib, Gefitinib, BIBW2992 |
| EGFR | 25% | COSM20881 | p.G719C | Substitution - Missense | 0.0424 | Afatinib, Erlotinib | Afatinib, Erlotinib, Gefitinib, BIBW2992 |
| EGFR | 25% | COSM12384 | p.E746_S752>V | Complex - deletion inframe | 0.0727 | Afatinib, Erlotinib | Afatinib, Erlotinib, Gefitinib, BIBW2992 |
| EGFR | 25% | COSM6213 | p.L861Q | Substitution - Missense | 0.0667 | Afatinib, Erlotinib | Afatinib, Erlotinib, Gefitinib, BIBW2992 |
| EGFR | 25% | COSM26352 | p.V769_D770insASV | Insertion - In frame | 0.0515 | Afatinib, Erlotinib | Afatinib, Erlotinib, Gefitinib, BIBW2992 |
| EGFR | 25% | COSM25873 | p.P772_H773insPR | Insertion - In frame | 0.0333 | Afatinib, Erlotinib | Afatinib, Erlotinib, Gefitinib, BIBW2992 |
| EGFR | 25% | COSM6252 | p.G719S | Substitution - Missense | 0.0303 | Afatinib, Erlotinib | Afatinib, Erlotinib, Gefitinib, BIBW2992 |
| EGFR | 25% | COSM18490 | p.D770_N771insSVD | Insertion - In frame | 0.0303 | Afatinib, Erlotinib | Afatinib, Erlotinib, Gefitinib, BIBW2992 |
| EGFR | 25% | COSM12988 | c.2125G>A | Substitution | 0.0242 | Afatinib, Erlotinib | Afatinib, Erlotinib, Gefitinib, BIBW2992 |
| EGFR | 25% | COSM23623 | p.H773R | Substitution - Missense | 0.0212 | Afatinib, Erlotinib | Afatinib, Erlotinib, Gefitinib, BIBW2992 |
| EGFR | 25% | COSM13424 | p.L833V | Substitution - Missense | 0.0212 | Afatinib, Erlotinib | Afatinib, Erlotinib, Gefitinib, BIBW2992 |
| EGFR | 25% | COSM12678 | p.E746_T751>A | Complex - deletion inframe | 0.0212 | Afatinib, Erlotinib | Afatinib, Erlotinib, Gefitinib, BIBW2992 |
| EGFR | 25% | COSM28009 | p.K745_A750del | Deletion - In frame | 0.0212 | Afatinib, Erlotinib | Afatinib, Erlotinib, Gefitinib, BIBW2992 |
| EGFR | 25% | COSM18491 | p.H773_V774insNPH | Insertion - In frame | 0.0212 | Afatinib, Erlotinib | Afatinib, Erlotinib, Gefitinib, BIBW2992 |
| EGFR | 25% | COSM24573 | p.L747_T751>P | Complex - deletion inframe | 0.0182 | Afatinib, Erlotinib | Afatinib, Erlotinib, Gefitinib, BIBW2992 |
| EGFR | 25% | COSM86965 | p.D770>GY | Complex - insertion inframe | 0.0151 | Afatinib, Erlotinib | Afatinib, Erlotinib, Gefitinib, BIBW2992 |
| EGFR | 25% | COSM28574 | p.P848L | Substitution - Missense | 0.0242 | Afatinib, Erlotinib | Afatinib, Erlotinib, Gefitinib, BIBW2992 |
| EGFR | 25% | COSM27111 | p.A871G | Substitution - Missense | 0.0151 | Afatinib, Erlotinib | Afatinib, Erlotinib, Gefitinib, BIBW2992 |
| EGFR | 25% | COSM30754 | p.L747P | Substitution - Missense | 0.0151 | Afatinib, Erlotinib | Afatinib, Erlotinib, Gefitinib, BIBW2992 |
| EGFR | 25% | COSM12376 | p.V769_D770insASV | Insertion - In frame | 0.0151 | Afatinib, Erlotinib | Afatinib, Erlotinib, Gefitinib, BIBW2992 |
| EGFR | 25% | COSM23571 | p.L747_T751delLREAT | Deletion - In frame | 0.0151 | Afatinib, Erlotinib | Afatinib, Erlotinib, Gefitinib, BIBW2992 |
| EGFR | 25% | COSM27101 | p.L747_E749del | Deletion - In frame | 0.0151 | Afatinib, Erlotinib | Afatinib, Erlotinib, Gefitinib, BIBW2992 |
| TP53 | 25% | COSM43617 | p.? | Substitution - Missense | 9.8864 | Nutlin-3a+ | Thapsigargin, EpothiloneB, OSU-03012, GNF-2 |
| TP53 | 25% | COSM10660 | p.R273H | Substitution - Missense | 1.6828 | Nutlin-3a+ | Thapsigargin, EpothiloneB, OSU-03012, GNF-2 |
| TP53 | 25% | COSM10779 | p.R273L | Substitution - Missense | 0.5469 | Nutlin-3a+ | Thapsigargin, EpothiloneB, OSU-03012, GNF-2 |
| TP53 | 25% | COSM10670 | p.V157F | Substitution - Missense | 0.4207 | Nutlin-3a+ | Thapsigargin, EpothiloneB, OSU-03012, GNF-2 |
| TP53 | 25% | COSM96438 | p.Y220C | Substitution - Missense | 0.2945 | Nutlin-3a+ | Thapsigargin, EpothiloneB, OSU-03012, GNF-2 |
| TP53 | 25% | COSM11081 | p.G245C | Substitution - Missense | 0.2945 | Nutlin-3a+ | Thapsigargin, EpothiloneB, OSU-03012, GNF-2 |
| TP53 | 25% | COSM43629 | p.R249W | Substitution - Missense | 0.2524 | Nutlin-3a+ | Thapsigargin, EpothiloneB, OSU-03012, GNF-2 |
| TP53 | 25% | COSM45647 | p.I254F | Substitution - Missense | 0.2524 | Nutlin-3a+ | Thapsigargin, EpothiloneB, OSU-03012, GNF-2 |
| TP53 | 25% | COSM10662 | p.R248Q | Substitution - Missense | 0.2524 | Nutlin-3a+ | Thapsigargin, EpothiloneB, OSU-03012, GNF-2 |
| TP53 | 25% | COSM44054 | p.L252F | Substitution - Missense | 0.2524 | Nutlin-3a+ | Thapsigargin, EpothiloneB, OSU-03012, GNF-2 |
| TP53 | 25% | COSM10991 | p.K132N | Substitution - Missense | 0.2524 | Nutlin-3a+ | Thapsigargin, EpothiloneB, OSU-03012, GNF-2 |
| TP53 | 25% | COSM10808 | p.Y163C | Substitution - Missense | 0.2524 | Nutlin-3a+ | Thapsigargin, EpothiloneB, OSU-03012, GNF-2 |
| TP53 | 25% | COSM6815 | p.G154V | Substitution - Missense | 0.2103 | Nutlin-3a+ | Thapsigargin, EpothiloneB, OSU-03012, GNF-2 |
| TP53 | 25% | COSM6549 | p.R248L | Substitution - Missense | 0.1683 | Nutlin-3a+ | Thapsigargin, EpothiloneB, OSU-03012, GNF-2 |
| TP53 | 25% | COSM10656 | p.R248W | Substitution - Missense | 0.1683 | Nutlin-3a+ | Thapsigargin, EpothiloneB, OSU-03012, GNF-2 |
| TP53 | 25% | COSM10817 | p.R249S | Substitution - Missense | 0.1683 | Nutlin-3a+ | Thapsigargin, EpothiloneB, OSU-03012, GNF-2 |
| TP53 | 25% | COSM10758 | p.Y220C | Substitution - Missense | 0.1683 | Nutlin-3a+ | Thapsigargin, EpothiloneB, OSU-03012, GNF-2 |
| TP53 | 25% | COSM10714 | p.R158L | Substitution - Missense | 0.1262 | Nutlin-3a+ | Thapsigargin, EpothiloneB, OSU-03012, GNF-2 |
| TP53 | 25% | COSM10785 | p.R249S | Substitution - Missense | 0.1262 | Nutlin-3a+ | Thapsigargin, EpothiloneB, OSU-03012, GNF-2 |
| TP53 | 25% | COSM10749 | p.C277F | Substitution - Missense | 0.1262 | Nutlin-3a+ | Thapsigargin, EpothiloneB, OSU-03012, GNF-2 |
| KRAS | 17% | COSM516 | p.G12C | Substitution - Missense | 7.3957 | Vorinostat, NVP-BEZ235, AZD8055, Azitinib, PD-173074, AZD6482, GDC0941, Methotrexate | PD-0325901, AZ628, CI-1040, RDEA119, AZD6244, OSI-906, TW37, Z-LLNle-CHO, TFH535, Methotrexate, JNK-9L |
| KRAS | 17% | COSM520 | p.G12V | Substitution - Missense | 4.0905 | Vorinostat, NVP-BEZ235, AZD8055, Azitinib, PD-173074, AZD6482, GDC0941, Methotrexate | PD-0325901, AZ628, CI-1040, RDEA119, AZD6244, OSI-906, TW37, Z-LLNle-CHO, TFH535, Methotrexate, JNK-9L |
| KRAS | 17% | COSM521 | p.G12D | Substitution - Missense | 3.8326 | Vorinostat, NVP-BEZ235, AZD8055, Azitinib, PD-173074, AZD6482, GDC0941, Methotrexate | PD-0325901, AZ628, CI-1040, RDEA119, AZD6244, OSI-906, TW37, Z-LLNle-CHO, TFH535, Methotrexate, JNK-9L |
| KRAS | 17% | COSM522 | p.G12A | Substitution - Missense | 1.2307 | Vorinostat, NVP-BEZ235, AZD8055, Azitinib, PD-173074, AZD6482, GDC0941, Methotrexate | PD-0325901, AZ628, CI-1040, RDEA119, AZD6244, OSI-906, TW37, Z-LLNle-CHO, TFH535, Methotrexate, JNK-9L |
| KRAS | 17% | COSM517 | p.G12S | Substitution - Missense | 0.6095 | Vorinostat, NVP-BEZ235, AZD8055, Azitinib, PD-173074, AZD6482, GDC0941, Methotrexate | PD-0325901, AZ628, CI-1040, RDEA119, AZD6244, OSI-906, TW37, Z-LLNle-CHO, TFH535, Methotrexate, JNK-9L |
| KRAS | 17% | COSM527 | p.G13C | Substitution - Missense | 0.6095 | Vorinostat, NVP-BEZ235, AZD8055, Azitinib, PD-173074, AZD6482, GDC0941, Methotrexate | PD-0325901, AZ628, CI-1040, RDEA119, AZD6244, OSI-906, TW37, Z-LLNle-CHO, TFH535, Methotrexate, JNK-9L |
| KRAS | 17% | COSM532 | p.G13D | Substitution - Missense | 0.504 | Vorinostat, NVP-BEZ235, AZD8055, Azitinib, PD-173074, AZD6482, GDC0941, Methotrexate | PD-0325901, AZ628, CI-1040, RDEA119, AZD6244, OSI-906, TW37, Z-LLNle-CHO, TFH535, Methotrexate, JNK-9L |
| KRAS | 17% | COSM518 | p.G12R | Substitution - Missense | 0.4219 | Vorinostat, NVP-BEZ235, AZD8055, Azitinib, PD-173074, AZD6482, GDC0941, Methotrexate | PD-0325901, AZ628, CI-1040, RDEA119, AZD6244, OSI-906, TW37, Z-LLNle-CHO, TFH535, Methotrexate, JNK-9L |
| KRAS | 17% | COSM14201 | p.Q61H | Substitution - Missense | 0.1641 | Vorinostat, NVP-BEZ235, AZD8055, Azitinib, PD-173074, AZD6482, GDC0941, Methotrexate | PD-0325901, AZ628, CI-1040, RDEA119, AZD6244, OSI-906, TW37, Z-LLNle-CHO, TFH535, Methotrexate, JNK-9L |
| KRAS | 17% | COSM21618 | COSM21618 | Substitution - Missense | 0.1406 | Vorinostat, NVP-BEZ235, AZD8055, Azitinib, PD-173074, AZD6482, GDC0941, Methotrexate | PD-0325901, AZ628, CI-1040, RDEA119, AZD6244, OSI-906, TW37, Z-LLNle-CHO, TFH535, Methotrexate, JNK-9L |
| KRAS | 17% | COSM25877 | p.G12D | Substitution - Missense | 0.1289 | Vorinostat, NVP-BEZ235, AZD8055, Azitinib, PD-173074, AZD6482, GDC0941, Methotrexate | PD-0325901, AZ628, CI-1040, RDEA119, AZD6244, OSI-906, TW37, Z-LLNle-CHO, TFH535, Methotrexate, JNK-9L |
| KRAS | 17% | COSM25878 | p.G12C | Substitution - Missense | 0.1055 | Vorinostat, NVP-BEZ235, AZD8055, Azitinib, PD-173074, AZD6482, GDC0941, Methotrexate | PD-0325901, AZ628, CI-1040, RDEA119, AZD6244, OSI-906, TW37, Z-LLNle-CHO, TFH535, Methotrexate, JNK-9L |
| KRAS | 17% | COSM555 | p.Q61H | Substitution - Missense | 0.0703 | Vorinostat, NVP-BEZ235, AZD8055, Azitinib, PD-173074, AZD6482, GDC0941, Methotrexate | PD-0325901, AZ628, CI-1040, RDEA119, AZD6244, OSI-906, TW37, Z-LLNle-CHO, TFH535, Methotrexate, JNK-9L |
| KRAS | 17% | COSM549 | p.Q61K | Substitution - Missense | 0.0586 | Vorinostat, NVP-BEZ235, AZD8055, Azitinib, PD-173074, AZD6482, GDC0941, Methotrexate | PD-0325901, AZ628, CI-1040, RDEA119, AZD6244, OSI-906, TW37, Z-LLNle-CHO, TFH535, Methotrexate, JNK-9L |
| KRAS | 17% | COSM552 | p.Q61R | Substitution - Missense | 0.0586 | Vorinostat, NVP-BEZ235, AZD8055, Azitinib, PD-173074, AZD6482, GDC0941, Methotrexate | PD-0325901, AZ628, CI-1040, RDEA119, AZD6244, OSI-906, TW37, Z-LLNle-CHO, TFH535, Methotrexate, JNK-9L |
| KRAS | 17% | COSM25881 | p.G12A | Substitution - Missense | 0.0469 | Vorinostat, NVP-BEZ235, AZD8055, Azitinib, PD-173074, AZD6482, GDC0941, Methotrexate | PD-0325901, AZ628, CI-1040, RDEA119, AZD6244, OSI-906, TW37, Z-LLNle-CHO, TFH535, Methotrexate, JNK-9L |
| KRAS | 17% | COSM25879 | p.G12V | Substitution - Missense | 0.0469 | Vorinostat, NVP-BEZ235, AZD8055, Azitinib, PD-173074, AZD6482, GDC0941, Methotrexate | PD-0325901, AZ628, CI-1040, RDEA119, AZD6244, OSI-906, TW37, Z-LLNle-CHO, TFH535, Methotrexate, JNK-9L |
| KRAS | 17% | COSM512 | p.G12 | Substitution - Missense | 0.0469 | Vorinostat, NVP-BEZ235, AZD8055, Azitinib, PD-173074, AZD6482, GDC0941, Methotrexate | PD-0325901, AZ628, CI-1040, RDEA119, AZD6244, OSI-906, TW37, Z-LLNle-CHO, TFH535, Methotrexate, JNK-9L |
| KRAS | 17% | COSM4169642 | p.G13C | Substitution - Missense | 0.0234 | Vorinostat, NVP-BEZ235, AZD8055, Azitinib, PD-173074, AZD6482, GDC0941, Methotrexate | PD-0325901, AZ628, CI-1040, RDEA119, AZD6244, OSI-906, TW37, Z-LLNle-CHO, TFH535, Methotrexate, JNK-9L |
| KRAS | 17% | COSM18793 | p.G13D | Substitution - Missense | 0.0234 | Vorinostat, NVP-BEZ235, AZD8055, Azitinib, PD-173074, AZD6482, GDC0941, Methotrexate | PD-0325901, AZ628, CI-1040, RDEA119, AZD6244, OSI-906, TW37, Z-LLNle-CHO, TFH535, Methotrexate, JNK-9L |
| KRAS | 17% | COSM1685355 | p.G13F | Substitution - Missense | 0.0234 | Vorinostat, NVP-BEZ235, AZD8055, Azitinib, PD-173074, AZD6482, GDC0941, Methotrexate | PD-0325901, AZ628, CI-1040, RDEA119, AZD6244, OSI-906, TW37, Z-LLNle-CHO, TFH535, Methotrexate, JNK-9L |
| KRAS | 17% | COSM553 | p.Q61L | Substitution - Missense | 0.0234 | Vorinostat, NVP-BEZ235, AZD8055, Azitinib, PD-173074, AZD6482, GDC0941, Methotrexate | PD-0325901, AZ628, CI-1040, RDEA119, AZD6244, OSI-906, TW37, Z-LLNle-CHO, TFH535, Methotrexate, JNK-9L |
| KRAS | 17% | COSM551 | p.Q61P | Substitution - Missense | 0.0117 | Vorinostat, NVP-BEZ235, AZD8055, Azitinib, PD-173074, AZD6482, GDC0941, Methotrexate | PD-0325901, AZ628, CI-1040, RDEA119, AZD6244, OSI-906, TW37, Z-LLNle-CHO, TFH535, Methotrexate, JNK-9L |
| KRAS | 17% | COSM1666976 | p.V14L | Substitution - Missense | 0.0117 | Vorinostat, NVP-BEZ235, AZD8055, Azitinib, PD-173074, AZD6482, GDC0941, Methotrexate | PD-0325901, AZ628, CI-1040, RDEA119, AZD6244, OSI-906, TW37, Z-LLNle-CHO, TFH535, Methotrexate, JNK-9L |
| KRAS | 17% | COSM1666974 | p.G13Y | Substitution - Missense | 0.0117 | Vorinostat, NVP-BEZ235, AZD8055, Azitinib, PD-173074, AZD6482, GDC0941, Methotrexate | PD-0325901, AZ628, CI-1040, RDEA119, AZD6244, OSI-906, TW37, Z-LLNle-CHO, TFH535, Methotrexate, JNK-9L |
| KRAS | 17% | COSM4944035 | COSM4944035 | Substitution - Missense | 0.0117 | Vorinostat, NVP-BEZ235, AZD8055, Azitinib, PD-173074, AZD6482, GDC0941, Methotrexate | PD-0325901, AZ628, CI-1040, RDEA119, AZD6244, OSI-906, TW37, Z-LLNle-CHO, TFH535, Methotrexate, JNK-9L |
| KRAS | 17% | COSM529 | p.G13R | Substitution - Missense | 0.0117 | Vorinostat, NVP-BEZ235, AZD8055, Azitinib, PD-173074, AZD6482, GDC0941, Methotrexate | PD-0325901, AZ628, CI-1040, RDEA119, AZD6244, OSI-906, TW37, Z-LLNle-CHO, TFH535, Methotrexate, JNK-9L |
| KRAS | 17% | COSM25880 | p.G12S | Substitution - Missense | 0.0117 | Vorinostat, NVP-BEZ235, AZD8055, Azitinib, PD-173074, AZD6482, GDC0941, Methotrexate | PD-0325901, AZ628, CI-1040, RDEA119, AZD6244, OSI-906, TW37, Z-LLNle-CHO, TFH535, Methotrexate, JNK-9L |
| KRAS | 17% | COSM550 | p.Q61E | Substitution - Missense | 0.0117 | Vorinostat, NVP-BEZ235, AZD8055, Azitinib, PD-173074, AZD6482, GDC0941, Methotrexate | PD-0325901, AZ628, CI-1040, RDEA119, AZD6244, OSI-906, TW37, Z-LLNle-CHO, TFH535, Methotrexate, JNK-9L |
| KRAS | 17% | COSM12721 | p.G13V | Substitution - Missense | 0.0117 | Vorinostat, NVP-BEZ235, AZD8055, Azitinib, PD-173074, AZD6482, GDC0941, Methotrexate | PD-0325901, AZ628, CI-1040, RDEA119, AZD6244, OSI-906, TW37, Z-LLNle-CHO, TFH535, Methotrexate, JNK-9L |
| ALK | 15% | COSM4422786 | p.L1196M | Substitution - Missense | 0.8696 | 17-AAG, ZM447439, p38, JNK2, AZ628, Crizotinib, Seliciclib, GW 441756, Methotrexate, CEP-701, Tretinoin, SB 216763, ABT-263 | PD-0332991, JNK Inhibitor VIII, Vinorelbine, Olaparib, Roscovitine |
| ALK | 15% | COSM4422788 | p.S1206Y | Substitution - Missense | 0.8696 | 17-AAG, ZM447439, p38, JNK2, AZ628, Crizotinib, Seliciclib, GW 441756, Methotrexate, CEP-701, Tretinoin, SB 216763, ABT-263 | PD-0332991, JNK Inhibitor VIII, Vinorelbine, Olaparib, Roscovitine |
| ALK | 15% | COSM28498 | p.I1171N | Substitution - Missense | 0.8696 | 17-AAG, ZM447439, p38, JNK2, AZ628, Crizotinib, Seliciclib, GW 441756, Methotrexate, CEP-701, Tretinoin, SB 216763, ABT-263 | PD-0332991, JNK Inhibitor VIII, Vinorelbine, Olaparib, Roscovitine |
| ALK | 15% | COSM97185 | p.L1152R | Substitution - Missense | 0.8696 | 17-AAG, ZM447439, p38, JNK2, AZ628, Crizotinib, Seliciclib, GW 441756, Methotrexate, CEP-701, Tretinoin, SB 216763, ABT-263 | PD-0332991, JNK Inhibitor VIII, Vinorelbine, Olaparib, Roscovitine |
| ALK | 15% | COSM99137 | p.L1196M | Substitution - Missense | 0.8696 | 17-AAG, ZM447439, p38, JNK2, AZ628, Crizotinib, Seliciclib, GW 441756, Methotrexate, CEP-701, Tretinoin, SB 216763, ABT-263 | PD-0332991, JNK Inhibitor VIII, Vinorelbine, Olaparib, Roscovitine |
| ALK | 15% | COSM4422790 | p.F1174C | Substitution - Missense | 0.8696 | 17-AAG, ZM447439, p38, JNK2, AZ628, Crizotinib, Seliciclib, GW 441756, Methotrexate, CEP-701, Tretinoin, SB 216763, ABT-263 | PD-0332991, JNK Inhibitor VIII, Vinorelbine, Olaparib, Roscovitine |
| ALK | 15% | COSM4422791 | p.F1174V | Substitution - Missense | 0.8696 | 17-AAG, ZM447439, p38, JNK2, AZ628, Crizotinib, Seliciclib, GW 441756, Methotrexate, CEP-701, Tretinoin, SB 216763, ABT-263 | PD-0332991, JNK Inhibitor VIII, Vinorelbine, Olaparib, Roscovitine |
| ALK | 15% | COSM99136 | p.C1156Y | Substitution - Missense | 0.8696 | 17-AAG, ZM447439, p38, JNK2, AZ628, Crizotinib, Seliciclib, GW 441756, Methotrexate, CEP-701, Tretinoin, SB 216763, ABT-263 | PD-0332991, JNK Inhibitor VIII, Vinorelbine, Olaparib, Roscovitine |
| ALK | 15% | COSM4440758 | p.I1171S | Substitution - Missense | 0.8696 | 17-AAG, ZM447439, p38, JNK2, AZ628, Crizotinib, Seliciclib, GW 441756, Methotrexate, CEP-701, Tretinoin, SB 216763, ABT-263 | PD-0332991, JNK Inhibitor VIII, Vinorelbine, Olaparib, Roscovitine |
| ALK | 15% | COSM4422787 | p.G1269A | Substitution - Missense | 1.7391 | 17-AAG, ZM447439, p38, JNK2, AZ628, Crizotinib, Seliciclib, GW 441756, Methotrexate, CEP-701, Tretinoin, SB 216763, ABT-263 | PD-0332991, JNK Inhibitor VIII, Vinorelbine, Olaparib, Roscovitine |
| ALK | 15% | COSM1169707 | p.G1269A | Substitution - Missense | 2.6087 | 17-AAG, ZM447439, p38, JNK2, AZ628, Crizotinib, Seliciclib, GW 441756, Methotrexate, CEP-701, Tretinoin, SB 216763, ABT-263 | PD-0332991, JNK Inhibitor VIII, Vinorelbine, Olaparib, Roscovitine |
| ALK | 15% | COSM4422789 | p.G1202R | Substitution - Missense | 2.6087 | 17-AAG, ZM447439, p38, JNK2, AZ628, Crizotinib, Seliciclib, GW 441756, Methotrexate, CEP-701, Tretinoin, SB 216763, ABT-263 | PD-0332991, JNK Inhibitor VIII, Vinorelbine, Olaparib, Roscovitine |
| CDKN2A | 11% | COSM13598 | p.? | Unknown | 3.01 | Cytarabine+, Docetaxel, Midostaurin, Temsirolimus | Salubrinal, ABT-263, PAC-1, Nutlin-3a |
| CDKN2A | 11% | COSM12525 | p.? | Unknown | 1.4214 | Cytarabine+, Docetaxel, Midostaurin, Temsirolimus | Salubrinal, ABT-263, PAC-1, Nutlin-3a |
| CDKN2A | 11% | COSM12526 | p.0? | Whole gene deletion | 1.1706 | Cytarabine+, Docetaxel, Midostaurin, Temsirolimus | Salubrinal, ABT-263, PAC-1, Nutlin-3a |
| CDKN2A | 11% | COSM12524 | p.? | Unknown | 1.087 | Cytarabine+, Docetaxel, Midostaurin, Temsirolimus | Salubrinal, ABT-263, PAC-1, Nutlin-3a |
| CDKN2A | 11% | COSM12523 | p.? | Unknown | 0.4181 | Cytarabine+, Docetaxel, Midostaurin, Temsirolimus | Salubrinal, ABT-263, PAC-1, Nutlin-3a |
| CDKN2A | 11% | COSM13281 | p.E69* | Subsititution-Missense | 0.3344 | Cytarabine+, Docetaxel, Midostaurin, Temsirolimus | Salubrinal, ABT-263, PAC-1, Nutlin-3a |
| CDKN2A | 11% | COSM13587 | p.0? | Whole gene deletion | 0.3344 | Cytarabine+, Docetaxel, Midostaurin, Temsirolimus | Salubrinal, ABT-263, PAC-1, Nutlin-3a |
| CDKN2A | 11% | COSM13964 | p.Y44* | Substitution-Missense | 0.2508 | Cytarabine+, Docetaxel, Midostaurin, Temsirolimus | Salubrinal, ABT-263, PAC-1, Nutlin-3a |
| CDKN2A | 11% | COSM13489 | p.D108Y | Substitution-Missense | 0.2508 | Cytarabine+, Docetaxel, Midostaurin, Temsirolimus | Salubrinal, ABT-263, PAC-1, Nutlin-3a |
| CDKN2A | 11% | COSM13530 | p.? | Unknown | 0.2508 | Cytarabine+, Docetaxel, Midostaurin, Temsirolimus | Salubrinal, ABT-263, PAC-1, Nutlin-3a |
| CDKN2A | 11% | COSM12547 | p.W110* | Substitution- Nonsense | 0.1672 | Cytarabine+, Docetaxel, Midostaurin, Temsirolimus | Salubrinal, ABT-263, PAC-1, Nutlin-3a |
| CDKN2A | 11% | COSM12476 | p.P114L | Substitution-Missense | 0.1672 | Cytarabine+, Docetaxel, Midostaurin, Temsirolimus | Salubrinal, ABT-263, PAC-1, Nutlin-3a |
| CDKN2A | 11% | COSM12473 | p.R58* | Substitution- Nonsense | 0.1672 | Cytarabine+, Docetaxel, Midostaurin, Temsirolimus | Salubrinal, ABT-263, PAC-1, Nutlin-3a |
| CDKN2A | 11% | COSM13567 | p.C72* | Substitution- Nonsense | 0.1672 | Cytarabine+, Docetaxel, Midostaurin, Temsirolimus | Salubrinal, ABT-263, PAC-1, Nutlin-3a |
| CDKN2A | 11% | COSM13717 | p.E69V | Substitution-Missense | 0.0836 | Cytarabine+, Docetaxel, Midostaurin, Temsirolimus | Salubrinal, ABT-263, PAC-1, Nutlin-3a |
| ATM | 7% | COSM12793 | p.E848Q | Substitution - Missense | 2.8571 | AZD6738 | AZD6738 |
| ATM | 7% | COSM12791 | p.T2666A | Substitution - Missense | 2.8571 | AZD6738 | AZD6738 |
| ATM | 7% | COSM12792 | p.L1794L | Substitution - coding silent | 2.8571 | AZD6738 | AZD6738 |
| ATM | 7% | COSM210743 | p.V997fs*1 | Unknown | 1.4286 | AZD6738 | AZD6738 |
| ATM | 7% | COSM210744 | p.N429fs*7 | Unknown | 1.4286 | AZD6738 | AZD6738 |
| UBR5 | 5% | COSM23129 | p.A414T | Substitution - Missense | 1.0753 | RF-C11 | RF-C11 |
| UBR5 | 5% | COSM3269474 | p.Q1533* | Substitution - Nonsense | 1.0753 | RF-C11 | RF-C11 |
| UBR5 | 5% | COSM23126 | p.V968I | Substitution - Missense | 1.0753 | RF-C11 | RF-C11 |
| UBR5 | 5% | COSM26913 | p.A870S | Substitution - Missense | 1.0753 | RF-C11 | RF-C11 |
| UBR5 | 5% | COSM25327 | p.F2023F | Substitution - coding silent | 1.0753 | RF-C11 | RF-C11 |
| CBL | 4% | COSM41272 | p.V391I | Substitution - Missense | 1.0638 | Erlotinib | Erlotinib |
| CBL | 4% | COSM41274 | p.A848T | Substitution - Missense | 0.5319 | Erlotinib | Erlotinib |
| CBL | 4% | COSM41270 | p.H94Y | Substitution - Missense | 0.5319 | Erlotinib | Erlotinib |
| CBL | 4% | COSM41591 | p.D460delD | Deletion - In frame | 0.5319 | Erlotinib | Erlotinib |
| CBL | 4% | COSM41273 | p.R830K | Substitution - Missense | 0.5319 | Erlotinib | Erlotinib |
| CBL | 4% | COSM41269 | p.S80N | Substitution - Missense | 0.5319 | Erlotinib | Erlotinib |
| CBL | 4% | COSM41275 | p.W802* | Substitution - Missense | 0.5319 | Erlotinib | Erlotinib |
| CBL | 4% | COSM41271 | p.Q249E | Substitution - Missense | 0.5319 | Erlotinib | Erlotinib |
| PIK3CA | 2% | COSM29328 | p.E545K | Substitution - Missense | 0.5161 | Methotrexate, PAC-1, VX-702 | AZD6482, AKTinhibitorVIII, AZD6482, Lapatinib, WZ1-84 |
| PIK3CA | 2% | COSM29329 | p.E542K | Substitution - Missense | 0.3226 | Methotrexate, PAC-1, VX-702 | AZD6482, AKTinhibitorVIII, AZD6482, Lapatinib, WZ1-84 |
| PIK3CA | 2% | COSM29325 | p.H1047R | Substitution - Missense | 0.1613 | Methotrexate, PAC-1, VX-702 | AZD6482, AKTinhibitorVIII, AZD6482, Lapatinib, WZ1-84 |
| PIK3CA | 2% | COSM763 | p.E545K | Substitution - Missense | 0.0968 | Methotrexate, PAC-1, VX-702 | AZD6482, AKTinhibitorVIII, AZD6482, Lapatinib, WZ1-84 |
| PIK3CA | 2% | COSM30744 | p.H1047L | Substitution - Missense | 0.0968 | Methotrexate, PAC-1, VX-702 | AZD6482, AKTinhibitorVIII, AZD6482, Lapatinib, WZ1-84 |
| PIK3CA | 2% | COSM29326 | p.H1047Y | Substitution - Missense | 0.0968 | Methotrexate, PAC-1, VX-702 | AZD6482, AKTinhibitorVIII, AZD6482, Lapatinib, WZ1-84 |
| PIK3CA | 2% | COSM775 | p.H1047R | Substitution - Missense | 0.0645 | Methotrexate, PAC-1, VX-702 | AZD6482, AKTinhibitorVIII, AZD6482, Lapatinib, WZ1-84 |
| PIK3CA | 2% | COSM29313 | p.M1043I | Substitution - Missense | 0.0645 | Methotrexate, PAC-1, VX-702 | AZD6482, AKTinhibitorVIII, AZD6482, Lapatinib, WZ1-84 |
| PIK3CA | 2% | COSM86997 | p.G1049S | Substitution - Missense | 0.0645 | Methotrexate, PAC-1, VX-702 | AZD6482, AKTinhibitorVIII, AZD6482, Lapatinib, WZ1-84 |
| PIK3CA | 2% | COSM760 | p.E542K | Substitution - Missense | 0.0645 | Methotrexate, PAC-1, VX-702 | AZD6482, AKTinhibitorVIII, AZD6482, Lapatinib, WZ1-84 |
| STK11 | 2% | COSM21212 | p.E57fs*7 | Deletion - Frameshift | 0.4435 | Metformin, Bryostatin, GW441756 | Metformin, Bryostatin, GW441756 |
| STK11 | 2% | COSM21360 | p.F354L | Substitution - Missense | 0.2217 | Metformin, Bryostatin, GW441756 | Metformin, Bryostatin, GW441756 |
| STK11 | 2% | COSM25854 | p.R409W | Substitution - Missense | 0.2217 | Metformin, Bryostatin, GW441756 | Metformin, Bryostatin, GW441756 |
| STK11 | 2% | COSM210753 | p.D194Y | Substitution - Missense | 0.2217 | Metformin, Bryostatin, GW441756 | Metformin, Bryostatin, GW441756 |
| RET | 2% | COSM1716552 | p.E623* | Substitution - Nonsense | 0.3484 | Vandetanib, Vandetanib, Cabozantinib | Vandetanib, Vandetanib, Cabozantinib |
| RET | 2% | COSM1716551 | p.I364fs*? | Unknown | 0.3484 | Vandetanib, Vandetanib, Cabozantinib | Vandetanib, Vandetanib, Cabozantinib |
| RET | 2% | COSM1716550 | p.R67H | Substitution - Missense | 0.3484 | Vandetanib, Vandetanib, Cabozantinib | Vandetanib, Vandetanib, Cabozantinib |
| RET | 2% | COSM538683 | p.R77L | Substitution - Missense | 0.3484 | Vandetanib, Vandetanib, Cabozantinib | Vandetanib, Vandetanib, Cabozantinib |
| RET | 2% | COSM12992 | p.R348R | Substitution - coding silent | 0.3484 | Vandetanib, Vandetanib, Cabozantinib | Vandetanib, Vandetanib, Cabozantinib |
| BRAF | 1% | COSM1131 | p.V600E | Substitution - Missense | 0.4796 | Axitinib, GDC0941, BIBW2992, AZD6482 | AZ628+, PLX4720, SB590885, RDEA119, PD-0325901, AZD6244, CI-1040, Nutlin-3a, CHIR-99021, ObatoclaxMesylate, Docetaxel |
| BRAF | 1% | COSM476 | p.V600E | Substitution - Missens | 0.2998 | Axitinib, GDC0941, BIBW2992, AZD6482 | AZ628+, PLX4720, SB590885, RDEA119, PD-0325901, AZD6244, CI-1040, Nutlin-3a, CHIR-99021, ObatoclaxMesylate, Docetaxel |
| BRAF | 1% | COSM470 | p.L597V | Substitution - Missense | 0.1199 | Axitinib, GDC0941, BIBW2992, AZD6482 | AZ628+, PLX4720, SB590885, RDEA119, PD-0325901, AZD6244, CI-1040, Nutlin-3a, CHIR-99021, ObatoclaxMesylate, Docetaxel |
| BRAF | 1% | COSM460 | p.G469A | Substitution - Missense | 0.1199 | Axitinib, GDC0941, BIBW2992, AZD6482 | AZ628+, PLX4720, SB590885, RDEA119, PD-0325901, AZD6244, CI-1040, Nutlin-3a, CHIR-99021, ObatoclaxMesylate, Docetaxel |
| BRAF | 1% | COSM460 | p.G469A | Substitution - Missense | 0.06 | Axitinib, GDC0941, BIBW2992, AZD6482 | AZ628+, PLX4720, SB590885, RDEA119, PD-0325901, AZD6244, CI-1040, Nutlin-3a, CHIR-99021, ObatoclaxMesylate, Docetaxel |
| BRAF | 1% | COSM29610 | p.G466V | Substitution - Missense | 0.06 | Axitinib, GDC0941, BIBW2992, AZD6482 | AZ628+, PLX4720, SB590885, RDEA119, PD-0325901, AZD6244, CI-1040, Nutlin-3a, CHIR-99021, ObatoclaxMesylate, Docetaxel |
| BRAF | 1% | COSM34031 | p.L485_P490>Y | Complex - deletion inframe | 0.03 | Axitinib, GDC0941, BIBW2992, AZD6482 | AZ628+, PLX4720, SB590885, RDEA119, PD-0325901, AZD6244, CI-1040, Nutlin-3a, CHIR-99021, ObatoclaxMesylate, Docetaxel |
| BRAF | 1% | COSM36377 | p.G466A | Substitution - Missense | 0.03 | Axitinib, GDC0941, BIBW2992, AZD6482 | AZ628+, PLX4720, SB590885, RDEA119, PD-0325901, AZD6244, CI-1040, Nutlin-3a, CHIR-99021, ObatoclaxMesylate, Docetaxel |
| BRAF | 1% | COSM26457 | p.D594N | Substitution - Missense | 0.03 | Axitinib, GDC0941, BIBW2992, AZD6482 | AZ628+, PLX4720, SB590885, RDEA119, PD-0325901, AZD6244, CI-1040, Nutlin-3a, CHIR-99021, ObatoclaxMesylate, Docetaxel |
| BRAF | 1% | COSM1155715 | p.G469del | Deletion - In frame | 0.03 | Axitinib, GDC0941, BIBW2992, AZD6482 | AZ628+, PLX4720, SB590885, RDEA119, PD-0325901, AZD6244, CI-1040, Nutlin-3a, CHIR-99021, ObatoclaxMesylate, Docetaxel |
| BRAF | 1% | COSM36245 | p.T599_V600insT | Insertion - In frame | 0.03 | Axitinib, GDC0941, BIBW2992, AZD6482 | AZ628+, PLX4720, SB590885, RDEA119, PD-0325901, AZD6244, CI-1040, Nutlin-3a, CHIR-99021, ObatoclaxMesylate, Docetaxel |
| BRAF | 1% | COSM27329 | p.D594G | Substitution - Missense | 0.03 | Axitinib, GDC0941, BIBW2992, AZD6482 | AZ628+, PLX4720, SB590885, RDEA119, PD-0325901, AZD6244, CI-1040, Nutlin-3a, CHIR-99021, ObatoclaxMesylate, Docetaxel |
| BRAF | 1% | COSM1155714 | p.G466R | Substitution - Missense | 0.03 | Axitinib, GDC0941, BIBW2992, AZD6482 | AZ628+, PLX4720, SB590885, RDEA119, PD-0325901, AZD6244, CI-1040, Nutlin-3a, CHIR-99021, ObatoclaxMesylate, Docetaxel |
| NRAS | 1% | COSM584 | p.Q61R | Substitution - Missense | 0.2149 | Gefitinib, Imatinib, Lenalidomide, AZD-0530 | MitomycinC, AZD6244, OSU-03012, CI-1040 |
| NRAS | 1% | COSM580 | p.Q61K | Substitution - Missense | 0.2149 | Gefitinib, Imatinib, Lenalidomide, AZD-0530 | MitomycinC, AZD6244, OSU-03012, CI-1040 |
| NRAS | 1% | COSM36378 | p.Q61L | Substitution - Missense | 0.1612 | Gefitinib, Imatinib, Lenalidomide, AZD-0530 | MitomycinC, AZD6244, OSU-03012, CI-1040 |
| NRAS | 1% | COSM583 | p.Q61L | Substitution - Missense | 0.2149 | Gefitinib, Imatinib, Lenalidomide, AZD-0530 | MitomycinC, AZD6244, OSU-03012, CI-1040 |
| NRAS | 1% | COSM589 | p.S65C | Substitution - Missense | 0.1075 | Gefitinib, Imatinib, Lenalidomide, AZD-0530 | MitomycinC, AZD6244, OSU-03012, CI-1040 |
| NRAS | 1% | COSM585 | p.Q61H | Substitution - Missense | 0.0537 | Gefitinib, Imatinib, Lenalidomide, AZD-0530 | MitomycinC, AZD6244, OSU-03012, CI-1040 |
| MET | 1% | COSM249781 | p.? | Unknown | 0.2457 | Lapatinib, Erlotinib, Crizotinib | Lapatinib, Erlotinib, Crizotinib, Onartuzumab |
| MET | 1% | COSM41592 | p.L211W | Substitution - Missense | 0.0819 | Lapatinib, Erlotinib, Crizotinib | Lapatinib, Erlotinib, Crizotinib, Onartuzumab |
| MET | 1% | COSM29311 | p.982_1028del47 | Deletion - In frame | 0.0819 | Lapatinib, Erlotinib, Crizotinib | Lapatinib, Erlotinib, Crizotinib, Onartuzumab |
| MET | 1% | COSM12876 | p.S283S | Substitution - coding silent | 0.0819 | Lapatinib, Erlotinib, Crizotinib | Lapatinib, Erlotinib, Crizotinib, Onartuzumab |
| MET | 1% | COSM29310 | p.Q1029_G1105del | Deletion - In frame | 0.0819 | Lapatinib, Erlotinib, Crizotinib | Lapatinib, Erlotinib, Crizotinib, Onartuzumab |
| MET | 1% | COSM29312 | p.982_1028del47 | Deletion - In frame | 0.0819 | Lapatinib, Erlotinib, Crizotinib | Lapatinib, Erlotinib, Crizotinib, Onartuzumab |
| MET | 1% | COSM144187 | p.G983S | Substitution - Missense | 0.0819 | Lapatinib, Erlotinib, Crizotinib | Lapatinib, Erlotinib, Crizotinib, Onartuzumab |
| MET | 1% | COSM707 | p.T1010I | Substitution - Missense | 0.0819 | Lapatinib, Erlotinib, Crizotinib | Lapatinib, Erlotinib, Crizotinib, Onartuzumab |
| PTEN | 1% | COSM5154 | p.R233* | Substitution - Nonsense | 0.1619 | Bosutinib, OSI-906, Methotrexate, BIBW2992 | TGX221, AZD6482, MK-2206, GDC0941 |
| PTEN | 1% | COSM5776 | p.? | Unknown | 0.1619 | Bosutinib, OSI-906, Methotrexate, BIBW2992 | TGX221, AZD6482, MK-2206, GDC0941 |
| PTEN | 1% | COSM26393 | p.R130Q | Substitution - Missense | 0.081 | Bosutinib, OSI-906, Methotrexate, BIBW2992 | TGX221, AZD6482, MK-2206, GDC0941 |
| PTEN | 1% | COSM5089 | p.R173C | Substitution - Missense | 0.081 | Bosutinib, OSI-906, Methotrexate, BIBW2992 | TGX221, AZD6482, MK-2206, GDC0941 |
| PTEN | 1% | COSM133102 | p.R173H | Substitution - Missense | 0.081 | Bosutinib, OSI-906, Methotrexate, BIBW2992 | TGX221, AZD6482, MK-2206, GDC0941 |
| PTEN | 1% | COSM5159 | p.Q245* | Substitution - Nonsense | 0.081 | Bosutinib, OSI-906, Methotrexate, BIBW2992 | TGX221, AZD6482, MK-2206, GDC0941 |
| PTEN | 1% | COSM5220 | p.G251C | Substitution - Missense | 0.081 | Bosutinib, OSI-906, Methotrexate, BIBW2992 | TGX221, AZD6482, MK-2206, GDC0941 |